Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany

被引：0
|
作者：
Greulich, T. [1 ]
Akyildiz, B. [2 ]
Nachtigall, D. [3 ]
Bogoevska, V [3 ]
Gessner, C. [4 ]
机构：
[1] Univ Klinikum Marburg, Klin Innere Med, Schwerpunkt Pneumol, Marburg, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Chiesi GmbH, Med Affairs, Hamburg, Germany
[4] Pois Leipzig Gbr DE, Praxis, Gessner & Gessner, Leipzig, Germany
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
10.1055/s-0043-1760936
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 151
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Slawinska, R.
    Wendt, A.
    Bogoevska, V
    Gessner, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Change in lung function after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Wendt, A.
    Licht, B.
    Criee, C.
    PNEUMOLOGIE, 2023, 77 : S36 - S36
  • [3] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
    Trinkmann, Autoren F.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S36
  • [4] Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Trinkmann, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Koczulla, A.
    Akyildiz, B.
    Slawinska, R.
    Martini, M.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S35
  • [6] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [7] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] Real-world evidence with extrafine single-inhaler triple therapy in asthma: the TriMaximize study
    Gessner, C.
    Akyildiz, B.
    Cesarz, K.
    Sauer, A.
    Bogoevska, V
    Criee, P. C.
    PNEUMOLOGIE, 2022, 76 : S7 - S8
  • [9] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and Health-related Quality of Life After Three Months of Treatment in Patients With Asthma: Trimaximize - A Real-world View From Germany, United Kingdom, Austria and Denmark
    Gessner, C.
    Akyildiz, B.
    Pohl, W.
    Nachtigall, D.
    Russell, R.
    Bogoevska, V.
    Ulrik, C. S.
    Watz, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment TriMaximize Study
    Gessner, C.
    Bogoevska, V
    Nachtigall, D.
    Akyildiz, B.
    Martini, M.
    Wendt, A.
    Criee, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
12345